Somatostatin analogues in the treatment of neuroendocrine system tumors
https://doi.org/10.14341/probl11628
Abstract
In recent years, significant progress has been made in understanding the biology and functional significance of somatostatin receptors (rCST) in various human tumors. The presence of functional rCST in tumors has clinical significance, which includes the ability, first, to control hormonal hypersecretion and the corresponding clinical symptoms through treatment with somatostatin analogues (SST); secondly, to conduct CCT scintigraphy, allowing in vivo to establish CCT-positive tumors and their metastases, and thirdly, to carry out pct-targeted radiotherapy using radiolabeled CST analogues.
About the Authors
I. I. DedovEndocrinological Research Center of RAMS
Russian Federation
V. V. Vaks
Endocrinological Research Center of RAMS
Russian Federation
References
1. Орел Н. Ф., Лопаткина Т. Н. // Consilium Medicum. -2000- Т. 2, № 1. - С. 28-32.
2. Abe Т., Ludecke D. // J. Endocrinol. - 2001. - Vol. 145, N 2. - Р. 137-145.
3. Ambrosio М., Franceschetti P., Bondanelli M. et al. // Metabolism. - 2002. - Vol. 51, N 3. - P. 387-393.
4. Aparicio T., Ducreux M., Baudin E. et al. // Eur. J. Cancer. -2001- Vol. 37, N 8. - P. 1014-1019.
5. Arnold R., Wied M., Behr T. H. // Exp. Opin. Pharmacother.2002. - Vol. 3, N 6. - P. 643-656.
6. Ashwell S., Bevan J., Edwards O. et al. // Eur. J. Endocrinol.2004. - Vol. 150, N 4. - P. 473-480.
7. Bertherat J., Brue T., Enjalbert A. et al. // J. Clin. Endocrinol. Metab. - 1992. - Vol. 75. - P. 540-546.
8. Caron P., Arlot S., Bauters C. et al. // J. Clin. Endocrinol. Metab. - 2001. - Vol. 86, N 6. - P. 2849-2853.
9. Chanson P., Weintraub B., Harris A. // Ann. Intern. Med. - 1993. - Vol. 119. - P. 236-240.
10. Chrisoulidou A., Pazaitou K, Drimonitis A. et al. // Eur. J. Endocrinol. - 2003. - Vol. 146. - Suppl. 1. - P. 108.
11. Coalo A., Ferone D., Marzullo P. et al. // J. Clin. Endocrinol. Metab. - 2001. - Vol. 86, N 6. - P. 2779-2786.
12. de Herder W., Hofland L., van der Lely A., Lamberts S. // En- docr. Relat. Cancer. - 2003. - Vol. 10, N 4. - P. 451-458.
13. Drange M., Melmed S. // J. Clin. Endocrinol. Metab. - 1998.Vol. 83, N 9. - P. 3104-3109.
14. Durani B., Klein A., Henze M. et al. // Br. J. Dermatol. -2003- Vol. 148, N 6. - P. 1135-1140.
15. Faiss S., Pape U., Bohmig M. et al. // J. Clin. Oncol. - 2003.Vol. 21, N 14. - P.2689-2696.
16. Ferone D., Pivonello R., Van Hagen P. et al. // Am. J. Physiol.2002. - Vol. 283, N 5. - P. 1056-1066.
17. Filippella M., Somma C., Ferrara G. et al. // Abstracts of 6-th European Congress of Endocrinology. - 2003. - Abstract Book. - P. 1060.
18. Froidevaux S., Eberle A. // Biopolymers. - 2002. - Vol. 66, N 3. - P. 161-183.
19. Gomez Merino E., Martinez A., Pozo J. et al. // An. Med. Interna. - 2003. - Vol. 20, N 1. - P. 52.
20. Hofland L., Lamberts S. // Ann. Oncol. - 2001. - Vol. 12. - Suppl. 2. - P. S31-S36.
21. Hofland L., van der Hoek J., van Koetsveld P. et al. // J. Clin. Endocrinol. Metab. -2004. - Vol. 89, N 4. - P. 1577-1585.
22. Imtiaz K., Monteith P., Khaleeli A. // Clin. Endocrinol. (Oxf.).2000. - Vol. 53, N 6. - P. 755-758.
23. Jaquet P., Ouafik L., Saveanu A. et al. // J. Clin. Endocrinol. Metab. - 1999. - Vol. 84, N 9. - P. 3268-3276.
24. Krausz Y., Bar-Ziv J., de Yong R. et al. // Am. J. Gastroenterol. - 1998. - Vol. 93, N 1. - P. 66-70.
25. Kuhn J., Arlot S., Lefebvre H. et al. // J. Clin. Endocrinol. Metab. - 2000. - Vol. 85, N 4. - P. 1487-1491.
26. Lamberts S., de Herder W., Hofland L. // Trends Endocrinol. Metab. - 2002. - Vol. 13, N 10. - P. 451-457.
27. Lombardi G., Colao A., Marzullo P. et al. // J. Endocrinol. Invest. - 2000. - Vol. 25, N 11. - P. 971-976.
28. Melmed S., Casanueva F., Cavagnini F. et al. // J. Clin. Endocrinol. Metab. - 2002. - Vol. 87, N 9. - P. 4054-4058.
29. Mosca A., Berruti A., Dogliotti L. et al. // Eur. J. Endocrinol.2003. - Vol. 146. - Suppl. 1. - P. 524.
30. Nielsen S., Mellemkjaer S., Rasmussen L. et al. // J. Endocrinol. Invest. - 2001. - Vol. 24, N 6. - P. 430-437.
31. Rohaizak M., Farndon J. // Aust. N. Z. J. Surg. - 2002. - Vol. 72, N 9. - P. 635-638.
32. Rubello D., Ruflni V., De Carlo E. et al. // Minerva Endocrinol. - 2003. - Vol. 28, N 4. - P. 259-296.
33. Ruszniewski P., Ducreux M., Chayvialle J. et al. // Gut. - 1996. - Vol. 39, N 2. - P. 279-283.
34. Shimon 1. // Endocrine. - 2003. - Vol. 20, N 3. - Р. 265- 270.
35. Smitha М., Maggi М., Orlando С. // Dig. Liver Dis. - 2004.Vol. 36. - Suppl. 1. - P. S78-S85.
36. Stokkel M., Reigman H., Verkooijen R., Smit J. // J. Cancer Res. Clin. Oncol. - 2003. - Vol. 129, N 5. - P. 287-294.
37. Thapar K., Kovacs K, Stefaneanu L. et al. // Mayo Clin. Proc.1997. - Vol. 72, N 10. - P. 893-900.
38. Theodoropoulou M., Stalla G., Pagotto U. et al. // Eur. J. Endocrinol. - 2003. - Vol. 146. - Suppl. 1. - P. 214.
39. Tsagarakis S.f Christoforaki M., Gianopoulou H. et al. // J. Clin. Endocrinol. Metab. - 2003. - Vol. 88, N 10. - P. 4754-4758.
40. van der Hoek J., de Herder W., Feelders R. et al. // J. Clin. Endocrinol. Metab. -2004. - Vol. 89, N 2. - P. 638-645.
41. van der Lely A., de Herder W., Krenning E., Kwekkeboom D. // Endocrine. - 2003. - Vol. 20, N 3. - P. 307-311.
42. van Thiel S., Romijn J., Biermasz N. et al. // Eur. J. Endocrinol. - 2004. - Vol. 150, N 4. - P. 489-495.
43. Vitale G., Pivonello R., Ferone D. et al. // Dig. Liver Dis. -2004- Vol. 36. - Suppl. 1. - P. S55-S59.
44. Was ко R., Jankowska A., Kotwicka M. et al. // Neuroendocri- nol. Lett. - 2003. - Vol. 24, N 5. - P. 334-338.
45. Wymenga A., Eriksson B., Salmela P. et al. //J. Clin. Oncol. - 1999. - Vol. 17, N 4. - P. 1111-1117.
46. Zatelli M., Piccin D., Tagliati F. et al. // Itinerary for ENDO: 84-th Annual Meeting. - 2002. - P. 2-142.
47. Zatelli M., Piccin D., Bondanelli M. et al. // Horm. Metab. Res. - 2003. - Vol. 35, N 6. - P. 349-354.
Review
For citations:
Dedov I.I., Vaks V.V. Somatostatin analogues in the treatment of neuroendocrine system tumors. Problems of Endocrinology. 2004;50(6):42-48. (In Russ.) https://doi.org/10.14341/probl11628
Views:
5614
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
.jpg){kind=logo}
